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Abstract The preparation of a recombinant protein using
Escherichia coli often involves a challenging primary recov-
ery sequence. This is due to the inability to secrete the protein
to the extracellular space without a significant degree of cell
lysis. This results in the release of nucleic acids, leading to a
high viscosity, difficulty to clarify, broth and also to contam-
ination with cell materials such as lipopolysaccharides and
host cell proteins. In this paper, we present different fermen-
tation strategies to facilitate the recovery of a VH domain an-
tibody (13.1 kDa) by directing it selectively to the extracellu-
lar space and changing the balance between domain antibody
to nucleic acid release. The manipulation of the cell growth
rate in order to increase the outer cell membrane permeability
gave a small ~1.5-fold improvement in released domain anti-
body to nucleic acid ratio without overall loss of yield. The
introduction during fermentation of release agents such as
EDTA gave no improvement in the ratio of released domain
antibody to nucleic acid and a loss of overall productivity. The
use of polyethyleneimine (PEI) during fermentation was with
the aim to (a) permeabilise the outer bacterial membrane to
release selectively domain antibody and (b) remove selective-
ly by precipitation nucleic acids released during cell lysis. This
strategy resulted in up to ~4-fold increase in the ratio of do-
main antibody to soluble nucleic acid with no reduction in
domain antibody overall titre. In addition, a reduction in host
cell protein contamination was achieved and there was no
increase in endotoxin levels. Similar results were demonstrat-
ed with a range of other antibody products prepared in E. coli.
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Introduction
Escherichia coli is the most widely used organism for the
production of proteins that do not require glycosylation. The
well-characterised genome, the ease of cultivation and the
rapid growth to high cell densities have contributed to its
popularity. As a gram-negative bacterium, E. coli can either
be used for recombinant protein expression in the cytoplasmic
or periplasmic space. Cytoplasmic protein expression usually
results in misfolding and aggregation of the heterologous pro-
tein into inclusion bodies. Also, the reducing environment of
the cytoplasm hinders the formation of disulfide bonds
(Baneyx and Mujacic 2004) and there is a need for cell lysis
in order to recover the product. Product expression in the
periplasmic space needs careful consideration of the method
of release from the cell where, for example, the extent of
release of protease and other degradative proteins especially
from the cytoplasm and long hold times, e.g. to achieve re-
lease, can lead to significant loss of protein product
(Kaufmann 1997).
Lysis of the cells results in a significant increase in viscos-
ity mainly due to the release of DNA (Balasundaram et al.
2009; Nesbeth et al. 2012) which has a negative effect on
the early centrifugation and filtration steps. Release by me-
chanical processes (Hubbuch et al. 2006; Li et al. 2013) or by
use of sonication or focussed acoustics (Li et al. 2012) can
result in a reduction of the nucleic acid molecular weight and
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hence of the viscosity, but this is accompanied by high levels
of cell debris attrition leading to difficult solid-liquid separa-
tion (Li et al. 2013). Nucleases may be used to degrade the
nucleic acids (Garke et al. 2000) or, to avoid the complexity at
manufacture scale of added biological agents, the E. coli host
engineered to co-express a nuclease (Balasundaram et al.
2009). The use of reagents such as polyethyleneimine (PEI)
has been shown to selectively flocculate cell debris and pre-
cipitate nucleic acids thereby making clarification of
homogenised or lysed ce l l s eas ier (Barany and
Szepesszentgyörgyi 2004; Chatel et al. 2014a).
The selective release of periplasmic products has been
demonstrated using osmotic shock (Rathore et al. 2003); the
use of EDTA to chelate Mg2+ and Ca2+ and hence, weaken the
outer membrane (OM) by destabilising the lipopolysaccha-
rides (LPS) leaflets (Jalalirad 2013); the use of chaotropic
agents such as guanidine and urea to weaken the OM resis-
tance (Falconer et al. 1997); the use of lysozyme to digest the
peptidoglycan of the cell wall (Pierce et al. 1997). The above
are generally applied to the harvested fermentation broth or
more selectively on the recovered cells. Challenges faced are
of scale up and achieving selective recovery away from cyto-
plasmic components. The successful release to the extracellu-
lar space of a periplasmic recombinant β-lactamase during
E. coli fermentation has been reported using EDTA and
phenethyl alcohol (Ryan and Parulekar 1991).
Directed extracellular secretion of a protein product might
be achieved by use of alternative hosts. For example use of
yeasts such as Pichia pastoris and Saccharomyces cerevisiae
can yield high expression titres but can cause unwanted glyco-
sylation and product degradation due to proteolysis (Johnson
2013; Potvin et al. 2012). Gram-positive Corynebacterium
glutamicum has been engineered to remove cell wall proteins
which act as permeability barriers to increase antibody frag-
ment secretion albeit at relatively low levels (Matsuda et al.
2014). For E. coli, a similar strategy has been used (Yoon
et al. 2010) as has (a) the co-expression of proteins that help
permeabilise the outer cell membrane such as the bacteriocin
release protein (Sommer et al. 2010) and the colicin E1 lysis
protein (Mergulhão et al. 2005), (b) the fusion of the target
protein with host cell proteins such as OM protein F (Jeong
and Lee 2002) or the osmotically inducible protein Yand YebF
(Zhang et al. 2006) to promote secretion (here, selective cleav-
age is needed to remove the secretion vector), (c) the use of
E. colimutants lacking genes for structural elements of the OM
and peptidoglycan layer (Shokri et al. 2003). Despite the en-
hanced product leakage demonstrated in all of these cases, these
strains are not appropriate for industrial high cell density pro-
duction since they are growth impaired, they are prone to pre-
mature lysis and they lack the necessary robustness (Mergulhão
et al. 2005; Shokri et al. 2003).
In this paper, we examine three fermentation-based strate-
gies to enhance the ratio in the extracellular space of domain
antibody product release to nucleic acid release. These include
the following: (i) the manipulation of carbon feed rate in order
to increase the outer cell membrane permeability, (ii) the in-
corporation of reagents within the broth designed to increase
the cell membrane permeability, (iii) the use of PEI to both
increase the cell OM permeability and remove selectively re-
leased nucleic acids.
Materials and methods
Fermentation method
An E. coliW3110 (ATCC® 27325TM) strain is used incorpo-
rating the pAVE011 plasmid (Hodgson et al. 2007) carrying
the gene for a VH anti-TNFR1 domain antibody of 13.1 kDa
(see Chatel et al. 2014b for gene sequence) fused to the OmpA
leader sequence (accession no. P0A910, Choi and Lee 2004;
Lee et al. 1998). The protein produced is from here on noted as
domain antibody (dAb). This construct was used for all fer-
mentation studies reported here. Three other E. coli constructs,
producing different antibody-related molecules, used to eval-
uate generality of main conclusions are briefly described in the
relevant BResults^ section.
Inoculum was prepared using 1 ml of glycerol (20 %, v/v)
stock of the cells (stored at −80 °C) introduced into 400 ml of
vLB inoculation medium in a 1000-ml baffled flask (Ultra
Yield Flask™ Thomson Instrument Company, Kent, UK) in
a rotary-shaking incubator at 220 rpm and 37 °C until OD600
reached 1. This was used to inoculate at 1:50v/v eight biore-
actors each of 1-l working volume (SR1000DLL bioreactor,
vessel diameter 100 mm, aspect ratio 2.4:1, overhead driven
triple Rushton 6-blade impellers (46-mm diameter), DASGIP
AG, Julich, Germany) charged with complex medium con-
taining glycerol as the main carbon source and yeast extract-
soytone. The reactor was maintained at pH 7.0±0.05 using
25 % (v/v) NH4OH and 2 M H3PO4 at temperatures of
30 °C before induction and 26 °C after induction; at DO of
30±5%, by cascade control using firstly impeller speed (400–
1600 rpm), secondly gas flow rate (1–2 vvm) and thirdly gas
oxygen content (21–100 %).
A DO spike was used to identify complete consumption of
glycerol and initiate a concentrated glycerol feed (containing
714 g/l glycerol, 50 g/l yeast extract), at 3.6 ml/l/h unless oth-
erwise stated. dAb formation was induced when the biomass
concentration had reached a level corresponding to OD600=80
±2, by addition of IPTG to a final concentration of 250 μM.
Real time values of pH, dissolved oxygen, agitation speed,
temperature, air-flow rate, oxygen percentage, oxygen uptake
rate and carbon dioxide evolution rate were recorded automat-
ically by the bioreactor software (DASGIP Control, Julich,
Germany). Each set of experiments was run in parallel using
duplicate fermentations and a commonly prepared inoculum.
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Variations in the above standard fermentation protocol in-
cluded the following: concentrated glycerol feed rates ranging
from 3.0 to 4.8 ml/l/h; use of continuous addition of 125 mM
EDTA (pH 7) and 125 mM EDTA 7.5 M urea (pH 7) initiated
at ~15 h post-induction at 5 ml/l/h; Tween 20 addition at 15 h
post-induction at 0.5 ml/l/h; batch addition of PEI (40 ml of
6.25 %w/v, giving at 23 h post-induction a final PEI concen-
tration of 0.25 % (w/v); continuous feed of 6.25 %w/v PEI,
solution initiated at 15 h post-induction at feed rates of 1.5 and
2.5 ml/l/h. The PEI used is branched of molecular weight
750 kDa (BASF, Ludwigshafen, Germany).
Analytical methods
The dAb product concentration was measured using protein A
affinity chromatography (HPLC Agilent 1200, Agilent Tech-
nologies UK Ltd., West Lothian, UK, fitted with a 1-ml
HiTrap MabSelectR Xtra, GE Healthcare Life Sciences,
Buckinghamshire, UK). Loading and equilibration were per-
formed using a 0.1-M PBS buffer at pH 7.2. Samples were
diluted appropriately in equilibration buffer and filtered using
0.22-μm PVDF syringe filter. Elution was performed using a
20mMHCl. Product elution was recorded at 220 nm and peak
areas integrated (Empower, Waters, Milford, USA).
Sample preparation for measurement of extracellular dAb
was by centrifugation of 1-ml broth at 24,200×g for 10 min
and the supernatant was 0.2-μm filtered. For intracellular dAb,
centrifuged pellet was re-suspended to 1 ml with 50 mM Tris
pH 8, subjected to four freeze-thaw cycles (freezing in dry ice
followed by incubation in a dry bath for 5 min at 37 °C) and
two freeze-sonication cycles (freezing in dry ice followed by
sonication for 15 min) using a sonication bath (Camsonix
C275, Elma Electronic GmbH, Singen, Germany). The soni-
cated samples were centrifuged at 24,200×g for 10 min and the
cell lysate recovered and 0.2-μm filtered. The intracellular dAb
extracted was tested for the presence of the signal peptide se-
quence for periplasmic secretion (in-house coupled size exclu-
sion chromatography - HPLC/Mass Spec analysis method,Wa-
ter Corp., Hertforshire, UK). Total dAb was by summation of
intracellular and extracellular measurements.
The viscosity measurements were carried out using a cup-
and-bob rheometer (Brookfield DV-2+ viscometer fitted with
spindle 40, Brookfield Engineering Laboratories, MA), ex-
posing 0.5 ml of cell broth to shear rates of 37 to 1200/s in
seven increments with 30-s hold at each increment, for in-
creasing and decreasing shear sweeps at 23 °C.
The concentration of the double-stranded DNA in the ex-
tracellular environment was determined using fluorometry
(Qubit 2.0 Fluorometer, Invitrogen, Carlsbad, CA, USA).
Sample preparation was as described above for dAb, but with-
out the 0.2-μm filtration step.
Cell culture analysis was by (a) optical density at 600 nm; (b)
gravimetrically as dry cell weight (DCW) using 1-ml samples
centrifuged at 24,200×g for 10 min and the recovered pellets
washed twice in distilledwater and then dried to constant weight
in an oven at 105 °C for 24 h; (c) capacitance was measured
online at 1000 kHz (Aber Instruments, Aberystwyth, UK).
The endotoxin levels in the broth supernatant were
measured using a commercial portable test system with
disposable cartridges containing Limulus amebocyte ly-
sate (LAL) following manufacturer ’s instructions
(Charles Rivers Laboratories, Charleston, SC, USA).
The concentration of the host cell proteins (HCP) in the
broth supernatant was measured using an in-house E. coli
anti-HCP sandwich ELISA method (GlaxoSmithKline,
Stevenage, UK).
Results
Figure 1 characterises the rheological properties of a range of
suspensions, including lysed cell broths, as a function of the
soluble DNA concentration. All solutions show characteristic
Fig. 1 Rheological properties of E. coli fermentation broths as a function
of extracellular DNA concentration. Open circles pre-induction 0–20 h,
cell concentration 0 to 30 g dwt/l; Filled circles post-induction 20–65 h,
cell concentration 30 to 40 g dwt/l. The rheological data is for power law
fits, τ=kγn, (R2=0.99), γ=37 to 1200/s for 30-s sweeps of both
increasing and decreasing shear (no significant difference). For [DNA]
>1000 mg/ml, some samples appeared to exhibit a high apparent yield
stress and did not shear. Temperature=23 °C
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pseudoplastic flow behaviour which is time independent and
fully reversible. Power law expressions adequately describe
the data obtained and the consistency index (equivalent to the
apparent viscosity at shear rate of 1/s) gives an indication of
the challenge which will be faced when trying to clarify by
centrifugation. A consistency index of ~0.03 Nsn/m2 obtained
at a DNA concentration of 600 mg/l is taken as the limit
defining challenging centrifugation (Voulgaris et al., to be
published). At this level of release, there was also visual evi-
dence of poor fermentation mixing conditions, e.g. appear-
ance of large air bubbles.
Figure 2 provides an example of the standard fermentation
used in this study. The post-induction time will be used to
follow fermentation progression. Intact cell concentration as
recorded by capacitance, peaks at 15 h; this is followed soon
after by a peak in dry cell weight (includes dying cells and cell
debris (Sonnleitner 2013) and a drop in cell respiration (lower
CER) at ~30 h (Fig. 2a). This profile is matched by the onset
of a significant rise in extracellular domain antibody (dAb)
and parallel reduction in intracellular dAb at 15 h and the
attainment of a maximum level of total dAb at 30 h
(Fig. 2b). No evidence was found of intracellular dAb con-
taining a signal peptide sequence; hence, from here on, intra-
cellular dAb refers to processed dAb available in the periplas-
mic space. The release of DNA (Fig. 2c) increases sharply at
the onset of a reduction in DCW and appears to parallel the
release of dAb except for an initial high level of DNA present
at the onset of induction.
A parity plot (Fig. 2d) follows dAb release with DNA
release. The parity line follows the release of dAb and DNA
from the initial value at induction to the maximum available
on complete disruption of whole cells and cell ghosts. The
maximum values are by measurement of dAb and for DNA
by estimation from themaximum cell dry weight; this is due to
Fig. 2 Formation of dAb fermentation and construction of parity plot
relating dAb and DNA release. a Profile of dry cell weight, capacitance,
and carbon dioxide evolution rate. b Profiles of extracellular, intracellular
and total dAb. c Profiles of DNA release to the extracellular space. d
Parity plot comparing release into extracellular environment of dAb and
DNA. One hundred percent DNA release=0.031* maximum cell DCW
(Neidhardt and Umbarger 1996). Construction: parity line (solid line) is
line of equal dAb and DNA release from induction (0 % dAb, 17 %
DNA); the DNA release boundary (dashed line) refers to the upper
limit beyond which the rheological proteins of the broth are such that
clarification by centrifugation is deemed to be overly challenging—see
text
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difficulties in the release of all DNA in an intact form for
measurement. The observed upper limit of 80 % of max-
imum available dAb might be defined as the target to be
achieved by release during fermentation, i.e. by cell au-
tolysis. An acceptable DNA release boundary of 60 % is
drawn in; i.e. equivalent to 600 mg/l (see Fig. 1). At this
DNA release limit, only ~40 % of the dAb has been re-
leased and the challenge is to find ways of moving above the
parity line to achieve high dAb recovery with acceptable
limited DNA release.
The effect of changing cell growth rate by adjustment of the
carbon source feed rate after induction and the resulting bal-
ance of dAb to nucleic acid release is explored in Fig. 3. The
range of feed rates chosen was based on a high-end value to
avoid excess glycerol accumulation and a low-end value be-
low which fermentation exceeds 50 h post-induction. Higher
feed rates appear to result initially in small (DCW basis) or no
(capacitance basis) increases in biomass levels and then earlier
lysis and ultimately lower biomass levels (Fig. 3a, b). The
CER values (Fig. 2c) reflect the increased biomass activity
(up to 20 h) and the earlier onset of lysis as the feed rate is
increased. As before, the DNA release (Fig. 3d) reflects the
extent of cell lysis. The final total intracellular and extracellu-
lar dAb levels are largely unaffected by the choice of feed rate
(Fig. 3e–g) but the higher rates of dAb formation at greater
feed rates reflects the higher biomass activity (Fig. 3c, g), and
the earlier release into the extracellular space at greater feed
rates reflects the earlier onset of cell lysis (Fig. 3a, b, e). The
resultant parity plot (Fig. 3h) shows that the greater the feed
rate, the higher the extent of release of dAb compared to DNA.
The improvement achieved increases the dAb yield from ~35
to ~58 % for 60 % DNA release. However, if the target is near
complete recovery of dAb, then it will, in all cases, be accom-
panied by ~100 % DNA release.
The use of cell permeabilising agents is explored in Fig. 4.
These agents were selected from literature (see Introduction)
and the concentrations used are based on laboratory-based
investigations of ranges of final concentrations of 15 to
75 mM EDTA, 0.5 to 2 M urea and 10 to 20 ml/l Tween 20
(results not shown here). The use of EDTA or EDTA-urea
results in a decrease in biomass as evidenced by lower values
of dry cell weight (Fig. 4a) and capacitance (Fig. 4b) and
reduced CER values (Fig. 4c). The resultant effect is low
released DNA levels and total dAb levels (Fig. 4d, g) but with
a significant proportion of the dAb appearing extracellularly
(Fig. 4e) evidently as a result of the increased cell wall
permeabilisation. As a result, there is an overall ~3-fold in-
crease in the ratio of the final dAb to the final DNA release.
This improvement is largely due to the reduced DNA levels
and indeed, recalibration of dAb release against the level of
dAb formed in the control brings all the EDTA and EDTA-
urea data points back to the parity line. The use of Tween
resulted in an earlier onset than the control in loss of active
biomass (Fig. 4a–c) but little difference in the released DNA
of dAb profiles (Fig. 4d–g) resulting in no improvement in the
ratio of dAb to DNA release (Fig. 4h). Also, high levels of
foaming were experienced. These strategies were not pursued
further as the small-scale screening trials indicated little room
for improvement with these particular reagents.
The use of PEI as both a potential release reagent and a
DNA precipitation reagent is studied using three feeding strat-
egies, namely in bulk as a single shot and continuously at low
or high feed rate (Fig. 5). The choice of feeding concentration
and quantity was to ensure sufficient PEI was present to pre-
cipitate the DNA to a maximum extent, and not so much as to
disturb the pH balance of the culture. In all cases, the use of
PEI resulted in an increased dry cell weight although evident-
ly, this measurement is compromised by the presence of PEI-
precipitated material. The capacitance and CER readings
(Fig. 5b, c) indicate the PEI had little effect on active biomass.
The increased capacitance observed (in duplicate) when using
bulk PEI addition might be due to liquid entrapped within cell
flocs formed relatively early in the induction phase by using
this method of addition. To note, there is a small but signifi-
cant increase in capacitance for continuous PEI feeds (not
observable in graphs shown); this is probably due to the same
reason of floc formation. The level of soluble DNA remains
low in the presence of PEI (Fig. 5d). For all the PEI feed
strategies tested, the proportion of dAb released is greater than
for the control as might be expected from the permeabilising
effect of PEI.Within this limited study, there is some evidence
for greater release with earlier onset of PEI addition and little
evidence for benefits of use of higher concentration of PEI
feed. Little effect is noted for any PEI addition strategy on
the resultant overall dAb level and location at the end of the
fermentation (Fig. 5e–g). The result is an overall~4-fold in-
crease in the ratio of dAb to DNA release which approaches
the maximum possible dAb which can be released by autoly-
sis, e.g. in comparison with the upper limit shown in Fig. 2d.
Since it is advantageous to avoid overdosing with PEI (carry
through of excess soluble PEI might affect performance of
later purification stages) the low concentration PEI feed strat-
egy was taken forward for further study. The choice of PEI
used, i.e. branched 750 kDa, is discussed later. Separate fer-
mentations, results not shown here, using branched 25 kDa
PEI, with the same continuous low feed rate administration as
used for the 750 kDa, resulted in high levels of early cell
death—to be discussed later.
Figure 6 summarises the performance of the various release
agents used in Figs. 4 and 5 in terms of the quality of the final
broth obtained. The dAb concentration at harvest remains
similar for the control-, Tween- and PEI-treated cultures while
the EDTA and EDTA-urea have significantly lower (~3-fold)
total and extracellular values. Figure 6b shows a ~3-fold
increase in endotoxin/extracellular dAb ratios for the EDTA
and EDTA-urea cultures. The PEI-treated cultures had
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endotoxin levels similar to the control and Tween 20 cultures.
The HCP released or remaining in broth is not affected by
Tween (compared with control) but is reduced ~2-fold for
EDTA, ~3-fold for EDTA-urea and ~1.3 fold for PEI.
Figure 6c shows that HCP/extracellular dAb ratios were sig-
nificantly higher for the EDTA but not the EDTA-urea-treated
cultures. PEI-treated cultures exhibited decreased levels of
HCP/extracellular dAb ratio which can either be attributed
to lower cell lysis during the PEI treatment or to precipita-
tion of some of these proteins by the polycation. Finally,
soluble DNA in the fermentation broth is ~5-fold lower for
the PEI culture compared to control and Tween 20 cultures.
EDTA- and EDTA-urea-treated cultures exhibited marginally
lower DNA/extracellular dAb ratios due to extracellular dAb
being threefold lower.
Figure 7 shows the effect of the PEI treatment on the
recombinant production of different antibody molecules in
E. coli culture. Antibody products 2, 3 and 4 are of MW
~25, 14 and 17 kDa. respectively. Figure 7a shows signifi-
cantly increased product release with the PEI application
while as time passes the difference between PEI treated
and control culture becomes less pronounced (Fig. 7b) espe-
cially for the larger antibody product 2 and, at the end of the
process, the levels of extracellular product are almost iden-
tical (Fig. 7c). The difference of concentration of the extra-
cellular soluble nucleic acids between the control- and PEI-
Fig. 3 Effect of carbon source
feed rate (see inset) on product
formation and comparative
product versus DNA release.
Time profiles of a dry cell weight,
b capacitance at 1000 kHz, c
carbon dioxide evolution rate, d
DNA release to the extracellular
space, e extracellular dAb
concentration, f intracellular dAb
concentration, g total dAb
concentration and DNA release to
the extracellular space and h
parity plot comparing release into
extracellular environment of both
dAb and DNA. The CER values
decline at 38, 32, 28 and 23 h
post-induction for the 3.0, 3.6, 4.2
and 4.8 ml/l/h feed rates,
respectively
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treated cultures is increased with time (Fig. 7d–f). As cells
are gradually releasing more nucleic acids, PEI precipitates
them retaining the concentration below 400 mg/l, i.e. below
critical level of 600 mg/l.
Discussion
One effect of increasing lysis during E. coli fermentation is the
release of nucleic acids leading to considerable increases in
broth viscosity (Nesbeth et al. 2012). This can lead to poorer
transport processes during fermentation especially at industri-
al scale (Gabelle et al. 2011), e.g. more challenging heat and
mass transfer and poorer mixing albeit at a time when cell
growth is largely complete so issues of nutrient supply and
metabolic heat removal are less demanding. The broth viscos-
ity is also an important factor affecting downstream processes
and in part icular, clarif icat ion by centrifugation
(Balasundaram et al. 2009) and filtration (Davies et al.
2000). For E. coli expression systems even where product is
secreted to the periplasmic space, release of product from the
cell is accompanied by equivalent release of DNA from the
cell (Fig. 2). However, it is only necessary to limit DNA re-
lease to ~60 % of total DNA while achieving near complete
product release to have a broth acceptable for processing.
Hence, the challenge is to manipulate fermentation conditions
Fig. 4 Effect of alternative
release strategies on dAb
formation and relative
extracellular concentrations of
dAb and DNA—see Fig. 3 for
key. For Fig. 3h, closed points are
for % dAb release against
maximum level achieved in
EDTA or EDTA-urea
fermentations; open points are for
% dAb release against maximum
as obtained in control. Operation
was as for the control culture with
a feed rate of 3.6 ml/l/h. Cultures
were treated with (i) EDTA
125 mM at 5 ml/l/h to final
[EDTA] of 18 mM, (ii) with
EDTA 125 mM urea 7.5 M at
5 ml/l/h to final [EDTA] of
18 mM and [urea] of 1 M, (iii)
Tween 20 incrementally over 23 h
(done in a controlled way to avoid
foaming) to a final concentration
of 20 ml/l. The line at 35 h
process time signifies the start of
the EDTA and EDTA-urea feed
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such that the cells preferentially release the product or the
released DNA at least in part is taken out of solution.
The effect of varying cell growth rate has been shown to
change the outer membrane phospholipid composition for
E. coli, increasing membrane fluidity and allowing periplas-
mic material to be released (Shokri et al. 2002). Also, for
E. coli, higher growth rates lead to reduced levels of the outer
membrane proteins OmpF and LamB which results in greater
membrane permeability (Bäcklund et al. 2008). These obser-
vations are consistent with the results reported in Fig. 3, where
for a limit of 60 % DNA release, the effect of greater feed rate
is to increase the dAb release from 35 to 58 %. However, for
near-complete dAb release, it is necessary to allow full cell
lysis and hence, high levels of DNA release. Consequently,
there is a need to explore ways to change the relationship
between dAb and DNA release during fermentation if oppor-
tunities are to be realised for earlier harvest and direct recovery
of dAb without further pretreatment.
EDTA is known to permeabilise cell membranes and hence
aid the release of proteins (Jalalirad 2013). For example, use
of EDTA in E. coli culture was successful in increasing the
levels of two recombinant enzymes, although a biomass drop
of 22 % was observed (Luo et al. 2014). The permeabilisation
is probably due to the interaction of EDTAwith the membrane
stabilising cations such as Mg2+ and Ca2+. These counterions
counteract the negative repulsive charges of the adjacent LPS
Fig. 5 Effect of alternative PEI
feed strategies on product
formation and relative
extracellular concentrations of
product and DNA—see Fig. 3 for
the key. Operation was as for the
control culture with a feed rate of
3.6 ml/l/h. Cultures were treated
with PEI to a final concentration
of 3 and 5 g/l, respectively, with a
low concentration continuous
feed of 1.5 ml/l/h for 32 h and a
high concentration of 5 g/l
continuous feed at 2.5 ml/l/h for
32 h. The vertical lines at 32 and
42 h process time signifying the
onset of the PEI feeds and PEI
bulk additions respectively
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molecules which link them electrostatically, and stabilise the
structure (Polissi and Sperandeo 2014).The damage of the
LPS leaflet compromises the integrity of the OM (Vaara
1992). However, the use of EDTA proves to be almost imme-
diately toxic to the cells (Fig. 4b, c). This might be due to the
sequestering of Fe3+ (Komárek et al. 2007), thereby depleting
Fig. 6 Impact of different cell
release strategies on a
extracellular and total dAb, and
per unit of extracellular dAb b
endotoxin, c HCP and d soluble
DNA. All fermentation carried
out for 45 h post induction and
reached a final cell density of
~25–30 g dwt/l. The release
agents were applied as described
in Figs. 4 and 5 (for the PEI
treatment the continuous low feed
was used)
Fig. 7 The effect of PEI treatment (1.5 ml/l/h) on product release and
soluble DNA concentration for four different recombinant antibody
fragment producing constructs (including for the dAb presented in
Figs. 2–6). Relative recoveries are given for 5 and 25 h after the onset
of the PEI treatment as well as at the harvest (50 h post-induction, 46 h
after start of PEI treatment). The relative extracellular product is the
proportional increase in released dAb (dAb released using PEI/dAb
released at harvest without PEI). Application of PEI started at ~4 h after
the induction of the recombinant antibody product
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iron containing proteins such as cytochrome and ferredoxin,
which are part of the electron transport chain and hence
reducing respiration. Moreover, iron is required in other pro-
cesses such as in amino acid and pyrimidine biosynthesis,
DNA synthesis and in superoxide radical protection (Earhart
1996). However, when the iron concentration exceeds cellu-
lar requirements, it is detrimental to the cell growth as it
promotes Fenton reaction causing DNA, protein, and lipid
damage (Imlay 2013). The use of chelating agents such as
EDTA should reduce such effects.
The EDTA treatment led to significantly lower amounts of
soluble DNA present (Fig. 4c). This may be partly attributed
to the lower biomass levels. The presence of EDTA protects
DNA from nuclease attack as it sequesters Mg2+ which acts as
cofactor (Yagi et al. 1996). However, such cation chelation
may destabilise the double-stranded state of DNA and lead
to its denaturation to a single-stranded form which is not de-
tected by the fluorometric method used in this paper
(Sedlackova et al. 2013). The capacitance data (Fig. 4b) sug-
gest that there is a sharp drop of the concentration of cells with
intact membranes, so it is unlikely the cells have entered a
metabolically inactive state where the cells remain intact.
The overall result is an apparent improvement in the rela-
tionship of dAb to DNA release (Fig. 4h) which, when the
lower dAb levels are taken into account, is effectively no
improvement in release selectivity over the control. The ef-
fects of decreases in broth viscosity on flow were apparent
(not shown here) probably due to reduced DNA levels; this
is in contrast to increased viscosity in the case of an Aspergil-
lus niger culture due to increased local hydrophobic interac-
tions between the mycelia (Berkman-Dik et al. 1992). The
EDTA-treated cultures had significantly higher endotoxin lev-
el per product (Fig. 6b) again due to the EDTA interaction
with the membrane-stabilising cations destabilising the OM
and releasing lipopolysaccharide molecules. The HCP levels
are significantly higher for the EDTA-treated cultures (Fig. 6c)
probably due to the extensive cell lysis as discussed earlier.
The use of urea in combination with EDTAwas studied to
explore if the chaotropic effect of urea on membrane lipids
(Jalalirad 2013) can improve dAb recovery. However, since
EDTA had so significantly reduced cell growth (Fig. 4a–c)
and remaining intracellular dAb (Fig. 4f), little effect could
be observed. The use of urea did lead to significantly lower
HCP levels present (Fig. 6) possibly due to denaturation of
some proteins leading to their removal by precipitation
(Bennion and Daggett 2003).
The non-ionic detergent Tween has been shown to
permeabilise the cell membrane by solubilising and remov-
ing the OM lipids (Jamur and Oliver 2010). An almost ~4-
fold increase in the activity of a recombinant enzyme from
0.6 to 2.2 % of the total activity has been documented when
Tween was applied in E. coli shake flasks (Luo et al. 2014).
While Tween had little effect on the cell growth and dAb
formation in the studies reported here, little to no effect was
also observed on the dAb release (Fig. 4h) or on the overall
contaminant profile (Fig. 6).
The use of PEI to help process harvested fermentation
broths is well known (Chatel et al. 2014b; Salt et al. 1995).
Here, we are concerned with the use of PEI during the fer-
mentation itself and the impact on live cells. For example, for
Salmonella typhirnurium, the effect of PEI is to redistribute
phospholipids from the inner to the outer layer and to enlarge
the OM surface area (Azevedo et al. 2014; Helander et al.
1998); for human cell lines, PEI induces membrane degrada-
tion and initiates apoptosis (Moghimi et al. 2005). For E. coli,
it has been suggested that PEI permeabilises the OM by inter-
calation (Alakomi et al. 2006). This, with the observation that
PEI does not cause significant disruption of the cytoplasmic
membrane, suggests that the cells remain viable while becom-
ing permeable (Gibney et al. 2012). This result is apparent in
Fig. 5 with enhanced leakage of dAb to the broth (Fig. 5e)
while the cells remain viable (Fig. 5a–c). The method of ad-
ministration of the PEI seems to have a significant effect on
the dAb release but this needs a more detailed study to char-
acterise sufficiently.
The impact of PEI on the LPS concentration in the culture
is complex. It has been observed that PEI do not release LPS
when it permeabilises the outer membrane (Alakomi et al.
2006). Similarly for Salmonella typhirnurium, while signifi-
cant LPS release occurs after treatment of cells with
permeabilisers such as EDTA, PEI causes no release
(Helander et al. 1997). However, if LPS is released, then at
neutral pHs, i.e. as during the fermentation, its partially phos-
phorylated carbohydrate residues will have a net negative
charge (Petsch et al. 1998) which should lead their removal
by precipitation. As such, PEI has been used for endotoxin
removal from systems as diverse as whole blood (Mitzner
et al. 1993), model endotoxin–protein mixtures and crude
E. coli lysates (Hanora et al. 2005). The low levels of LPS
release observed when using PEI in E. coli fermentations
(Fig. 6) might either be the result of little to no LPS release
or LPS precipitation or both.
As with LPS, it is unclear if the decreased HCP and DNA
levels (Fig. 6) are due to reduced lysis or due to precipitation
or a combination of both. PEI is very potent at binding and
precipitating negatively charged macromolecules such as
DNA, RNA, and proteins bound to DNA or RNA, as well
as acidic proteins (Mazzaferro et al. 2010). Similar results of
DNA and lipid reduction, due to removal by PEI precipitation,
have been reported in culture homogenates (Salt et al. 1995).
Likewise, PEI has been shown to precipitate colloidal protein
(Salt et al. 1995) and this might be the mechanism of HCP
reduction noted here. At post-induction times of ~50 h, the
indication is that the cells in the presence of PEI have started to
lyse but probably not to the same extent as for the control
without PEI (Fig. 5a–c). Here, the PEI will be acting as a
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precipitating agent while earlier in the fermentation, it may
have promoted the dAb release with reduced DNA or other
intracellular component release. The analytical methods used
here were not able to distinguish between the twomechanisms
as there is a need for sample preparation to fractionate the
precipitate from the cells and cell ghosts.
Evidently, there may be other effects of PEI on cell metabo-
lism to be taken into account. For example, PEI inhibits biofilm
formation in Staphylococcus and Acinitobacter species
(Azevedo et al. 2014) and in E. coli (Alakomi et al. 2006) which
might improve bioreactor performance by avoiding energy- and
nutrient-wasteful biofilm synthesis and improving mass and
heat transfer (Sung et al. 2006). PEI enhances antibiotic pene-
tration (Khalil et al. 2008) and hence might enhance the segre-
gation stability of the cultivating culture by avoiding plasmid
loss. It is also possible that PEI-related early release of dAb from
the periplasm will reduce pressure on the cell physiology.
The choice of PEI form andmolecular weight might offer an
important means for optimising its use during fermentation. In
this study, the choice wasmade primarily based on the ability of
PEI to precipitate selectively released cell components. High
molecular weight branched PEI was used due to its high hydro-
phobicity which results in a reduced number of polymer chains
available to interact with the bacterial cell membrane and hence
lower toxicity (Gibney et al. 2012). Also, the high branched
750 kDa PEI will not pass through the OM due to its larger
structure and therefore will destabilise only the OM. In contrast,
lower molecular weight and linear PEI will be less likely to be
trapped by the outer membrane anionic LPS and peptidoglycan
(Gibney et al. 2012; Takahashi et al. 2013) and hence, there is a
higher possibility of destabilisation or destruction of the inner
membrane (e.g. as noted in the BResults^ use of 25 kDa PEI led
to significant cell death).
Figure 7 demonstrates the application of use of PEI during
fermentation for three other cell constructs preparing different
dAb-related proteins. In all cases, the PEI has an immediate
positive effect on the release of the product, the ratio of product
to soluble DNA is enhanced, the final product titre is un-
changed compared to the control and, when full release of the
final product is achieved, the level of soluble DNA remaining is
well below the limit to yield broths suitable for clarification by
continuous centrifugation at manufacturing scale.
Some key conclusions are as follows:
(i) The use of increased feed rates to enhance cell growth rate
not only helps reduce fermentation time but gives a small
preferential release of the dAb compared with DNA. How-
ever, this advantage is not realised at high levels of dAb
release as might be required in manufacture.
(ii) The use of EDTA probably helps permeabilise the cells,
but it prevents cell growth; hence precluding its use to
after fermentation is completed rather than during
fermentation.
(iii) The use of PEI during fermentation does not cause any
adverse effects on cell growth or on dAb formation and
does enhance the release into the broth of the dAb. Fur-
thermore, the presence of PEI leads to reduced levels of
soluble HCP, LPS and DNA, the last of which is pre-
dicted to result in a broth which will be easier to process
by continuous centrifugal clarification at large scale.
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